MBX Biosciences, Inc.
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 439.98M | 373.71M | 391.67M | 224.91M | 240.79M |
| Total Receivables | 3.16M | 2.12M | 1.55M | 841.00K | 1.39M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.59M | 4.85M | 3.40M | 2.97M | 1.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 814.00K | 861.00K | 882.00K | 472.00K | 626.00K |
| Total Current Assets | 448.54M | 381.54M | 397.50M | 229.19M | 244.28M |
|
|
|||||
| Total Current Assets | 448.54M | 381.54M | 397.50M | 229.19M | 244.28M |
| Net Property, Plant & Equipment | 3.59M | 3.22M | 2.52M | 2.28M | 1.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 579.00K | 383.00K | 50.00K | 51.00K | 50.00K |
| Total Assets | 452.70M | 385.14M | 400.08M | 231.52M | 245.93M |
|
|
|||||
| Total Accounts Payable | 6.97M | 2.98M | 3.77M | 5.76M | 4.25M |
| Total Accrued Expenses | 7.42M | 12.35M | 8.14M | 5.85M | 6.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 178.00K | 172.00K | 154.00K | 138.00K | 130.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.57M | 15.50M | 12.06M | 11.76M | 10.48M |
|
|
|||||
| Total Current Liabilities | 14.57M | 15.50M | 12.06M | 11.76M | 10.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 377.00K | 424.00K | 469.00K | 512.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00K | 2.00K | 7.00K | 15.00K | 23.00K |
| Total Liabilities | 14.95M | 15.92M | 12.54M | 12.28M | 10.50M |
|
|
|||||
| Common Stock & APIC | 686.36M | 593.41M | 589.80M | 400.02M | 396.75M |
| Retained Earnings | -247.99M | -224.48M | -202.41M | -180.80M | -161.39M |
| Treasury Stock & Other | -606.00K | 286.00K | 154.00K | 11.00K | 53.00K |
| Total Common Equity | 437.76M | 369.22M | 387.54M | 219.24M | 235.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 437.76M | 369.22M | 387.54M | 219.24M | 235.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 437.76M | 369.22M | 387.54M | 219.24M | 235.42M |
|
|
|||||